未登录

K

Knut Erik Berge

Oslo University Hospital

H指数:37

被引数:8,122

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cardiac function and the effect of heart failure treatment in patients with genotype-positive dilated cardiomyopathy

基因阳性扩张型心肌病患者的心脏功能及心力衰竭治疗的效果

JACC-Heart Failure

IF11.8

2026-08-280

OA

LDL-cholesterol in newborns and children with genetically verified familial hypercholesterolaemia: implications for cholesterol-based screening

新生儿和患有基因确诊家族性高胆固醇血症的儿童的LDL-cholesterol：胆固醇筛查的启示

EUROPEAN HEART JOURNAL

IF35.6

2025-10-010

PRE

Relationship between physical and psychological functioning and health-related quality of life in congenital Aniridia

ACTA OPHTHALMOLOGICA

IF2.8

2023-12-220

OA

Vigorous exercise in patients with hypertrophic cardiomyopathy

INTERNATIONAL JOURNAL OF CARDIOLOGY

IF3.2

2018-01-0164

OAAI

Lamin A/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation

EUROPEAN HEART JOURNAL

IF35.6

2017-10-31201

OAAI

Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics

LIPIDS IN HEALTH AND DISEASE

IF4.2

2017-06-1230

OAAI

Rapid molecular diagnostics of severe primary immunodeficiency determined by using targeted next-generation sequencing

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IF11.2

2016-10-0160

PREAI

IDENTIFICATION AND CHARACTERIZATION OF TWO NOVEL MUTATIONS IN THE LPL GENE CAUSING TYPE I HYPERLIPOPROTEINEMIA

ATHEROSCLEROSIS

IF5.7

2016-09-010

OAAI

Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia

JOURNAL OF CLINICAL LIPIDOLOGY

IF4.6

2016-07-0134

OAAI

Type 1 hyperlipoproteinemia due to a novel deletion of exons 3 and 4 in the GPIHBP1 gene

由于GPIHBP1基因中外显子3和4的新缺失而导致的1型高脂蛋白血症

ATHEROSCLEROSIS

IF5.7

2014-05-0113

PREAI

Risk prediction of ventricular arrhythmias and myocardial function in Lamin A/C mutation positive subjects

IF7.4

2013-09-2083

OAAI

PCSK9-mediated degradation of the LDL receptor generates a 17 kDa C-terminal LDL receptor fragment

JOURNAL OF LIPID RESEARCH

IF4.1

2013-06-0140

OAAI

Mutations in the SORT1 gene are unlikely to cause autosomal dominant hypercholesterolemia

ATHEROSCLEROSIS

IF5.7

2012-12-0117

PREAI

Description of a Large Family with Autosomal Dominant Hypercholesterolemia Associated with the APOE p.Leu167del Mutation

IF3.7

2012-10-11111

OA

Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor-independent pathways

TRANSLATIONAL RESEARCH

IF5.9

2012-08-0132

PREAI

Characterization of a naturally occurring degradation product of the LDL receptor

MOLECULAR GENETICS AND METABOLISM

IF3.5

2012-01-0116

PREAI

Interaction between the ligand-binding domain of the LDL receptor and the C-terminal domain of PCSK9 is required for PCSK9 to remain bound to the LDL receptor during endosomal acidification

HUMAN MOLECULAR GENETICS

IF3.2

2011-12-0859

OAAI

Role of the C-terminal domain of PCSK9 in degradation of the LDL receptors

JOURNAL OF LIPID RESEARCH

IF4.1

2011-10-0162

OAAI

Affinity and kinetics of proprotein convertase subtilisin/kexin type 9 binding to low-density lipoprotein receptors on HepG2 cells

IF4.2

2011-07-1813

OAAI

Mutations in APOA-I and ABCA1 in Norwegians with low levels of HDL cholesterol

HDL胆固醇水平低的挪威人的apoa-i和ABCA1突变

CLINICA CHIMICA ACTA

IF2.9

2010-12-0115

PREAI